Retatrutide: The Next Generation Triple Hormone Agonist for Weight Loss
THE LAB — TRIM FITT CLINICAL RESEARCH Compounded GLP-1 medication: The Next Generation Triple Hormone Agonist for Weight Loss Reviewed by the TRIM FITT Clinical Team · Evidence-Based Medicine The evolution of GLP-1 therapy has been rapid — from semaglutide’s dual-mechanism success to tirzepatide’s superior dual agonism, the field is now entering a new era […]
Tirzepatide vs Semaglutide: Which GLP-1 Therapy is Right for You?
THE LAB — TRIM FITT CLINICAL RESEARCH Tirzepatide vs Semaglutide: Which GLP-1 Therapy is Right for You? Reviewed by the TRIM FITT Clinical Team · Evidence-Based Medicine If you’ve been exploring medical weight loss options, you’ve likely encountered both semaglutide and tirzepatide. While both are GLP-1 receptor agonists that have revolutionized metabolic medicine, they work […]
Semaglutide for Weight Loss: What the Clinical Trials Really Show
THE LAB — TRIM FITT CLINICAL RESEARCH Semaglutide for Weight Loss: What the Clinical Trials Really Show Reviewed by the TRIM FITT Clinical Team · Evidence-Based Medicine Semaglutide has transformed the conversation around medically supervised weight loss. Originally developed as a treatment for type 2 diabetes, semaglutide — marketed under brand names like Ozempic and […]